Get the Stockscreener App
14.24
2.93%
-0.43
After Hours:
14.24
Edgewise Therapeutics Inc stock is traded at $14.24, with a volume of 573.62K.
It is down -2.93% in the last 24 hours and up +6.35% over the past month.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
See More
Previous Close:
$14.67
Open:
$14.7
24h Volume:
573.62K
Relative Volume:
0.77
Market Cap:
$1.50B
Revenue:
-
Net Income/Loss:
$-150.70M
P/E Ratio:
-9.1871
EPS:
-1.55
Net Cash Flow:
$-125.67M
1W Performance:
-8.54%
1M Performance:
+6.35%
6M Performance:
-43.47%
1Y Performance:
-18.95%
1-Day Range:
$14.20
$14.74
1-Week Range:
$14.20
$15.61
52-Week Range:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Name
Edgewise Therapeutics Inc
Sector
Industry
Phone
720-262-7002
Address
1715 38TH ST, BOULDER
Compare EWTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.24 | 1.55B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Initiated | Raymond James | Strong Buy |
| Jun-30-25 | Initiated | H.C. Wainwright | Buy |
| Apr-30-25 | Initiated | Guggenheim | Buy |
| Apr-02-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jan-22-25 | Initiated | Stifel | Hold |
| Nov-22-24 | Initiated | Evercore ISI | Outperform |
| Mar-07-24 | Initiated | Piper Sandler | Overweight |
| May-01-23 | Initiated | Truist | Buy |
| Aug-25-22 | Downgrade | Goldman | Neutral → Sell |
| Apr-13-22 | Initiated | RBC Capital Mkts | Outperform |
| Jan-28-22 | Initiated | Goldman | Neutral |
View All
Edgewise Therapeutics Inc Stock (EWTX) Latest News
Woodline Partners LP Raises Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Parkman Healthcare Partners LLC Acquires 44,234 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Adage Capital Partners GP L.L.C. Acquires 150,000 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Granahan Investment Management LLC Has $4.79 Million Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Eventide Asset Management LLC Acquires Shares of 568,310 Edgewise Therapeutics, Inc. $EWTX - MarketBeat
EFG Asset Management North America Corp. Acquires 63,048 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Cormorant Asset Management LP Buys 695,458 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Issues Inducement Grants Covering 50,000 Shares to New Employees - geneonline.com
Can Edgewise Therapeutics Inc. be the next market leaderDip Buying & Free Accurate Trade Setup Notifications - beatles.ru
MPM Bioimpact LLC Buys 26,128 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Braidwell LP Buys 126,612 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Is it time to cut losses on Edgewise Therapeutics Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser
Edgewise Therapeutics, Inc. $EWTX Position Raised by First Light Asset Management LLC - MarketBeat
Understanding Edgewise Therapeutics Inc.’s price movement2025 Investor Takeaways & Weekly High Return Stock Opportunities - Newser
Is Edgewise Therapeutics Inc. gaining market shareEarnings Recap Report & Fast Exit and Entry Strategy Plans - خودرو بانک
Is Edgewise Therapeutics Inc. stock poised for growthTrade Entry Report & Consistent Profit Alerts - Newser
Intraday pattern recognizer results for Edgewise Therapeutics Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - Newser
Will Edgewise Therapeutics Inc. outperform the marketMarket Activity Recap & Accurate Intraday Trading Signals - Newser
What is the target price for Edgewise Therapeutics Inc. stockQuarterly Market Summary & Precise Swing Trade Entry Alerts - خودرو بانک
Edgewise Therapeutics, Inc. $EWTX Shares Sold by Wellington Management Group LLP - MarketBeat
Should you hold or exit Edgewise Therapeutics Inc. nowSwing Trade & Weekly Top Performers Watchlists - Newser
Edgewise Therapeutics Inc. stock daily chart insightsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - Newser
What’s the recovery path for long term holders of Edgewise Therapeutics Inc.July 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How to manage a losing position in Edgewise Therapeutics Inc.Portfolio Gains Report & Consistent Profit Trade Alerts - Newser
Is Edgewise Therapeutics Inc. a potential multi baggerWeekly Earnings Recap & AI Driven Stock Reports - خودرو بانک
What high frequency data says about Edgewise Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - Newser
Quantitative breakdown of Edgewise Therapeutics Inc. recent move2025 Volatility Report & Consistent Growth Stock Picks - Newser
Is Edgewise Therapeutics Inc. a cyclical or defensive stockJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Driehaus Capital Management LLC Sells 118,049 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Is Edgewise Therapeutics Inc. stock entering bullish territoryJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - 富途牛牛
Edgewise Therapeutics shares fall 3.59% premarket after reporting inducement grants to new employees. - AInvest
What moving averages say about Edgewise Therapeutics Inc.Portfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Edgewise Therapeutics' Strategic Use of Inducement Grants to Fuel Long-Term Growth in a High-Potential Biopharma Sector - AInvest
Automated trading signals detected on Edgewise Therapeutics Inc.Earnings Beat & Weekly High Potential Stock Alerts - Newser
Siren L.L.C. Raises Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Will Edgewise Therapeutics Inc. outperform tech stocksTrade Performance Summary & High Conviction Buy Zone Picks - خودرو بانک
16,500 Stock Options at $14.35: Edgewise Therapeutics Awards Inducement Grants to New Hires - Stock Titan
Signal strength of Edgewise Therapeutics Inc. stock in tech scannersWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Edgewise Therapeutics Inc Stock (EWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):